Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
La Revue Du Praticien|March 24, 2011
[Current management of myelodysplastic syndromes]Norbert Vey, Aude Charbonnier
International Immunology|July 4, 2002
Generation of potent T(h)1 responses from patients with lymphoid malignancies after differentiation of B lymphocytes into dendritic-like cellsMohamad Mohty, Daniel Isnardon, Aude Charbonnier, et al.
Leukemia Research|December 22, 2007
Common features of myeloproliferative disorders with t(8;9)(p12;q33) and CEP110-FGFR1 fusion: report of a new case and review of the literatureMarie-Joëlle Mozziconacci, Nadine Carbuccia, Thomas Prebet, et al.
Cancer|October 20, 2010
Improved outcome of patients with low- and intermediate-risk cytogenetics acute myeloid leukemia (AML) in first relapse with gemtuzumab and cytarabine versus cytarabine: results of a retrospective comparative studyThomas Prebet, Anne Etienne, Raynier Devillier, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 3, 2012
Human Vγ9Vδ2 T cells specifically recognize and kill acute myeloid leukemic blastsJulie Gertner-Dardenne, Remy Castellano, Emilie Mamessier, et al.
Frontiers in Immunology|February 18, 2017
Kinetics of Cytotoxic Lymphocytes Reconstitution after Induction Chemotherapy in Elderly AML Patients Reveals Progressive Recovery of Normal Phenotypic and Functional Features in NK CellsJérôme Rey, Cyril Fauriat, Eloïse Kochbati, et al.
Leukemia & Lymphoma|May 16, 2012
Combination of cytarabine and topotecan in patients treated for acute myeloid leukemia with persistent disease after frontline inductionThomas Prébet, Estelle Jean, Aurélie Autret, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 23, 2019
Alternative Effective and Safe Induction Regimens for Newly Diagnosed Acute Myeloid Leukemia in Patients With Cardiac Contraindication to AnthracyclinesClemence Marcault, Geoffroy Venton, Lauris Gastaud, et al.
Cancer|February 28, 2007
Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemiaAnne Etienne, Benjamin Esterni, Aude Charbonnier, et al.
Leukemia & Lymphoma|December 3, 2016
Phase 1 dose-escalation study of oral abexinostat for the treatment of patients with relapsed/refractory higher-risk myelodysplastic syndromes, acute myeloid leukemia, or acute lymphoblastic leukemiaNorbert Vey, Thomas Prebet, Claire Thalamas, et al.
Pageof 7